PTC Therapeutics股价在FDA批准PKU治疗药物后飙升

英为财情
Jul 29, 2025

Investing.com -- 在宣布美国食品药品监督管理局(FDA)已批准其药物SEPHIENCE(sepiapterin)用于治疗苯丙酮尿症(PKU)后,PTC Therapeutics (NASDAQ:PTCT)股价上涨了9%。 此次批准包括广泛的适应症,用于治疗1个月及以上年龄的成人和儿科患者中对sepiapterin有反应的PKU引起的高苯丙氨酸血症(HPA)。这一全面的适应症允许公司...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10